Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Wiad Lek ; 75(10): 2407-2411, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36472269

RESUMO

OBJECTIVE: The aim: To analyze the dynamics of daily monitoring of blood pressure, intracardiac (according to echocardiography), peripheral hemodynamics (according to ultrasound of the vessels of the lower extremity), the thickness of the intima-media complex (according to carotid sonography) in patients with hypertension the effect of treatment with a combination of lisinopril and amlodipine. PATIENTS AND METHODS: Materials and methods: The study included 40 patients with hypertension with 2 (29 patients) and 3 (11 patients) degrees of hypertension in combination with AOLE with I-III stages of chronic insufficiency of the lower extremity, which revealed hyperkinetic, eukinetic, and hypokinetic types of hypertension with a predominance of the sympathetic nervous system. The groups are comparable in age, sex, duration of hypertension, and medications received in the previous stages. For antihypertensive therapy, the most common drugs for use were selected - lisinopril + amplodipine in fixed doses of 10 and 5 mg, respectively. If after 2 weeks we did not reduce the mean level of SBP and DBP by 10% or more from baseline, we doubled the dose of lisinopril without changing the dose of amlodipine. RESULTS: Results: After 6 months of treatment, in particular, an increase in the pulse index - by 24.8%, a decrease in the resistance index - by 21.1%, an increase in linear and volumetric blood velocity - by 25.6% and 27.4%, respectively, while achieving the target blood pressure. CONCLUSION: Conclusions: It is proved that in the absence of individual contraindications the combination of lisinopril and amlodipine is optimal and universal for effective treatment of patients with hypertension in combination with AOLE in all types of central hemodynamics.


Assuntos
Arteriosclerose Obliterante , Medicina Geral , Hipertensão , Humanos , Anlodipino/uso terapêutico , Anlodipino/farmacologia , Lisinopril/uso terapêutico , Lisinopril/farmacologia , Anti-Hipertensivos/uso terapêutico , Anti-Hipertensivos/farmacologia , Arteriosclerose Obliterante/induzido quimicamente , Arteriosclerose Obliterante/tratamento farmacológico , Hipertensão/complicações , Hipertensão/tratamento farmacológico , Pressão Sanguínea , Comorbidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...